Delaware Court Agrees with CytoDyn that Activist Group’s Nominations are Invalid - Yahoo! Finance -BoardProspects

Delaware Court Agrees with CytoDyn that Activist Group’s Nominations are Invalid

Yahoo! Finance Oct 14 2021 BoardNews

CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that the Delaware Court of Chancery found that CytoDyn’s Board of Directors properly rejected a nomination notice presented by an activist group led by Paul Rosenbaum and Bruce Patterson...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Why Should We Care About Corporate Interlocks? also categorized in BoardNews
- Have the Swiss Gone Cuckoo? also categorized in BoardNews
- The Other Duty of Corporate Governance also categorized in BoardNews
- Getting Gen-Y on Boards (of Directors) also categorized in BoardNews
- 20 Taiwan Businesspeople To Watch -- James Kuo, Austin Liu and Andy Lu also categorized in BoardNews
- Transocean chairman Talbert to retire also published in Yahoo! Finance
- Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews
- Corporate Governance and the Problem of Executive Compensation also mentions Delaware
- Germany's Corporate Governance Problem also categorized in BoardNews
- Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews

Search:
Categories
1. BoardProspects Features:
  Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned